Etichub was featured in a recent interview with Il Sole 24 Ore, where our CEO, Dr. Mariella Bleve, highlighted the company’s growth journey and Etichub’s innovative role in the cosmetic sector and applied research.
A Winning Model Between Science and Industry
During the interview, Dr. Bleve emphasized how Etichub continues to establish itself as a strategic partner for companies in the cosmetic industry, thanks to a unique consulting and scientific approach.
For us, innovation is a crucial element in Etichub’s growth, enabling us to continuously develop cutting-edge solutions. We invest in a young and excellent team, with an active PNRR industrial PhD program, and in advanced technologies such as the Filament Surface Tester (FST), an innovative tool for advanced hair analysis, and Dermaslync®, a technology for skin treatment. Additionally, we own registered trademarks such as Actilivery®, an active ingredient encapsulation system.
The growth in 2024 has been significant, and for this reason, our development plan for the near future is based on key strategic pillars: innovative solutions through technology transfer, internationalization with expansion into various markets, and service diversification, including the industrial development of the FST device.
